Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Primary Myelofibrosis × trametinib × Clear all

Sponsor

Conditions

Melanoma 25 Neoplasms 11 Carcinoma, Non-Small-Cell Lung 6 Neoplasm Metastasis 4 Multiple Myeloma 4 Hematologic Neoplasms 4 Lymphoma 3 Brain Neoplasms 3 Biliary Tract Neoplasms 3 Skin Neoplasms 2 Leukemia, Myeloid, Acute 2 Glioma 2 Colorectal Neoplasms 2 Cholangiocarcinoma 2 Bile Duct Neoplasms 2 Uveal Melanoma 1 Triple Negative Breast Neoplasms 1 Thyroid Carcinoma, Anaplastic 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Oligodendroglioma 1 Nonseminomatous germ cell tumor 1 Neurofibromatosis 1 1 Neurocytoma 1 Myelodysplastic Syndromes 1 Mouth Neoplasms 1 Lung Neoplasms 1 Leukemia, Myelomonocytic, Juvenile 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Hairy Cell 1 Klatskin Tumor 1

Interventions

fludarabine phosphate 27 Cyclophosphamide 24 Whole-Body Irradiation 19 Mycophenolic Acid 19 Tacrolimus 16 Busulfan 16 ruxolitinib 15 Peripheral Blood Stem Cell Transplantation 14 Antilymphocyte Serum 14 fludarabine 13 Melphalan 12 Cyclosporine 10 thymoglobulin 9 Methotrexate 9 Sirolimus 6 Etoposide 6 Cord Blood Stem Cell Transplantation 6 Radiotherapy 5 Granulocyte Colony-Stimulating Factor 5 Stem Cell Transplantation 4 Cyclosporins 4 Azacitidine 4 pomalidomide 3 Surveys and Questionnaires 3 Rituximab 3 Prednisone 3 Filgrastim 3 11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 3 parsaclisib 2 itacitinib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡